Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Statement

2 Nov 2017 07:00

RNS Number : 3058V
Elektron Technology PLC
02 November 2017
 

Elektron Technology plc

("Elektron", the "Group" or the "Company")

 

Trading Update

 

Elektron Technology plc (AIM: EKT), the global technology group, is pleased to provide an update on trading for the third quarter ended 31 October 2017.

Sales

Group trading was strong in Q3 with sales increasing 34% compared to the same period last year to £8.6m (2017: £6.4m). Year to date sales have increased by 15% to £22.9m (2017: £19.9m).

Bulgin achieved record quarterly sales of £7.8m in Q3, 37% higher than the same period last year (2017: £5.7m) following successful manufacturing scale-up to convert the unprecedented order demand in H1 into sales. The board expects that Bulgin sales will revert to more normal levels through Q4.

 

Sales £m

Unaudited

Unaudited

Q3 2018

Q3 2017

YTD 2018

YTD 2017

Bulgin

7.8

5.7

20.3

17.4

IMC (Queensgate and Elektron Eye Technology)

0.7

0.7

2.3

2.3

Checkit

0.1

0.3

0.2

 

Total

 

8.6

 

6.4

 

22.9

 

19.9

 

Orders

Group order intake remains well ahead of prior year, with all business segments demonstrating growth.

Bulgin and IMC orders are both 20% above prior year levels year to date.

Checkit has continued to build recurring revenue streams and total contracted annual recurring revenue (including forthcoming contracted installations) now stands at £0.7m, compared with £0.3m at the same time last year (+133%).

Cash

Group net cash was approximately £3.0m at 31 October 2017 (31 July 2017: £2.0m; 31 January 2017: £1.0m) following the initial proceeds from the Sheen Instruments disposal of £1.1m in October. The net cash position has also been impacted by investment in working capital of approximately £0.4m as a result of the strong trading performance in this quarter.

John Wilson, Chief Executive Officer of Elektron, said:

"Q3 trading has been strong. The Board now expects full year performance to be ahead of its previous expectations."

Enquiries:

 

Elektron Technology plc 

www.elektron-technology.com

 

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

 

Andy Weatherstone - Chief Financial Officer & Company Secretary

 

 

 

finnCap (Nominated Adviser & Broker)

+44 (0)20 7220 0500

Ed Frisby / Scott Mathieson - Corporate Finance

 

Abigail Wayne - Corporate Broking

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

Notes to Editors

Elektron conceives designs and markets innovative engineered products and services for businesses that connect, monitor and control. We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

 

- Demand for ubiquitous power and data: Bulgin

- New waves of "aware" business applications: Checkit

- The effect of ageing on sight: Elektron Eye Technology

- Growth in high precision manufacture: Queensgate

 

Cautionary statement

This financial information has been prepared only for the shareholders of Elektron as a whole and its sole purpose and use is to assist shareholders to exercise their governance rights. Elektron and its Directors and employees are not responsible for any other purpose or use or to any other person in relation to this report.

The report contains indications of likely future developments and other forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. Key risks and their mitigation have not changed materially in the period from those disclosed on pages 12 to 14 of the annual financial statements for the year ended 31 January 2017.

These and other factors could adversely affect the Group's results, strategy and prospects. Forward-looking statements involve risks, uncertainties and assumptions. They relate to events and/or depend on circumstances in the future which could cause actual results and outcomes to differ materially from those currently anticipated. No obligation is assumed to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUBDBCSGBGRB
Date   Source Headline
30th Jul 20247:00 amRNSBoard changes
10th Jul 20247:00 amRNSSurrender and grant of options and PDMR dealings
2nd Jul 20247:00 amRNSContract Win
27th Jun 20247:00 amRNSSuccessful conclusion of VAT recoverability case
26th Jun 20247:00 amRNSIntention not to make an offer for Crimson Tide
24th Jun 20245:30 pmRNSForm 8.3 - Checkit Plc
24th Jun 202411:59 amRNSForm 8.5 (EPT/RI)
21st Jun 202410:36 amRNSForm 8.5 (EPT/RI)
20th Jun 202410:47 amRNSForm 8.5 (EPT/RI)
20th Jun 202410:46 amRNSForm 8.3 - Checkit plc - Amendment
19th Jun 202411:54 amRNSForm 8.5 (EPT/RI)
18th Jun 20245:31 pmRNSForm 8.3 - Checkit Plc
18th Jun 20244:23 pmRNSForm 8.3 - Checkit Plc
14th Jun 20246:10 pmRNSForm 8.3 - Checkit PLC
14th Jun 202412:14 pmRNSForm 8.3 - Checkit plc
14th Jun 202411:00 amRNSForm 8.5 (EPT/RI)
14th Jun 20249:42 amRNSForm 8.3 - Checkit plc
13th Jun 202411:37 amRNSForm 8.5 (EPT/RI)
12th Jun 20243:22 pmRNSForm 8 (OPD) - Checkit plc
12th Jun 202411:49 amRNSForm 8.5 (EPT/RI)
12th Jun 20249:29 amRNSForm 8.5 (EPT/RI) - Replacement
12th Jun 20249:19 amRNSForm 8.3 - Checkit plc
12th Jun 20247:00 amRNSContract Wins
11th Jun 20246:15 pmRNSForm 8.3 - Checkit plc - Amendment
11th Jun 20246:14 pmRNSForm 8.3 - Crimson Tide plc - Amendment
11th Jun 202412:04 pmRNSForm 8.5 (EPT/RI)
10th Jun 202412:43 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - OPD - Checkit PLC
10th Jun 202411:56 amRNSForm 8.5 (EPT/RI) - Checkit PLC
10th Jun 20248:54 amRNSForm 8.3 - Checkit plc
7th Jun 20247:00 amRNSResults of Annual General Meeting
6th Jun 202411:51 amRNSForm 8.5 (EPT/RI)
5th Jun 20245:17 pmRNSForm 8.3 - Checkit plc
5th Jun 20243:06 pmGNWForm 8.3 - Checkit Plc
5th Jun 202411:58 amRNSForm 8.5 (EPT/RI)
5th Jun 202411:57 amRNSForm 8.3 - Checkit PLC
4th Jun 202410:48 amPRNForm 8 (OPD) - Checkit PLC
4th Jun 20247:00 amRNSPossible Offer for Crimson Tide plc
29th Apr 20242:59 pmRNSDirector/PDMR Shareholding
25th Apr 20247:00 amRNSFinal Results
17th Apr 20242:35 pmRNSNotice of Results and Investor Presentation
15th Apr 20247:00 amRNSNew Product Launch and Contract Wins
14th Mar 20248:49 amRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSGrant of Options and PDMR Dealings
8th Mar 20249:00 amRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSInvestor Presentation
1st Feb 20242:25 pmRNSSurrender of Existing Options
7th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSInterim Results
24th Aug 20237:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.